Anastasija Komkova and Thomas Fast from ApHER conducted analyses in a research project examining the healthcare resource utilization and medication burden in epilepsy patients before and after initiating the antiepileptic drug perampanel. The project was presented in a poster at ISPOR 2019 in New Orleans, LA, on May 18-22. Further information and link for the poster [...]
Presenting work and receiving feedback is a rewarding part in our scientific work. Thomas Fast presented our Narcolepsy project at the 6th Nordic Narcolepsy Symposium in Uppsala and the project can now move forward with the aim of publishing the results in a scientific journal. Read about the symposium here: https://lnkd.in/d_xAWXE
ApHER participated at ISPOR Europe 2018 and presented a study “COSTS OF MULTIPLE SCLEROSIS IN DENMARK: A REGISTER BASED STUDY”. The unique registers in Denmark allow us to include in the study all individuals with Multiple Sclerosis (MS) in Denmark. All Individuals with MS in 2014 were ascertained and characterized by treatment from the Danish health [...]
Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]
In collaboration, Dr. Hans Martens and APEHR have completed a blog discussing the challenge of chronic disease for Europe's health systems. Link to the blog.
